Latest Financial Targets News

Page 1 of 7
Expeditors has outlined a long-term growth model targeting 5% to 7% annual revenue growth and 12% to 15% EPS growth. The logistics group also issued Q4 and full-year 2026 EPS guidance while flagging artificial intelligence, automation and potential acquisitions as part of its growth plan.
Maxwell Dee
Maxwell Dee
19 Nov 2026
Nike has laid out a five-year recovery plan targeting US$5 billion in incremental revenue by fiscal 2031, but the near-term picture remains difficult. Fiscal 2027 revenue is still expected to fall by a high-single-digit percentage, with restructuring costs weighing on earnings.
Logan Eniac
Logan Eniac
18 Nov 2026
Alcidion has entered FY27 with record contracted revenue, a debt-free balance sheet and reaffirmed guidance for revenue and underlying EBITDA to exceed FY26. Shareholders also approved a 10-for-1 share consolidation as the healthcare software company weighs buy-backs, acquisitions and further platform investment.
Victor Sage
Victor Sage
12 Nov 2026
PEXA has sharply lowered its FY27 revenue and profit expectations after Australian Exchange volumes fell 11.5% in the first quarter. Stable market share and customer satisfaction offer some support, but October transfer volumes were down 26% and a regulatory pricing decision remains pending.
Victor Sage
Victor Sage
11 Nov 2026
Microchip Technology delivered a stronger-than-expected fiscal second quarter, with sales up 42.2% and earnings above its own guidance. The chipmaker expects seasonal softness in the December quarter, but says demand, bookings and design wins remain firm.
Victor Sage
Victor Sage
6 Nov 2026
Viatris has lifted its 2026 guidance midpoints across revenue, adjusted EBITDA, adjusted EPS and free cash flow after a resilient third quarter. The upgrade comes alongside a US$1.65 billion Pacira acquisition and a costly manufacturing suspension in India.
Victor Sage
Victor Sage
5 Nov 2026
HP has turned to former GSK chief Emma Walmsley to lead the company from January, handing her a compensation package featuring a US$30 million inducement equity award. Interim CEO Bruce Broussard will become chair as the company prepares a significant leadership reset.
Sophie Babbage
Sophie Babbage
5 Nov 2026
Axtec has proposed fintech founder Andy Taylor as its next Managing Director and CEO, pairing the appointment with a A$1 million share placement and a plan to expand beyond real estate payments. The leadership change remains conditional on Taylor completing his cornerstone investment and finalising employment terms.
Victor Sage
Victor Sage
4 Nov 2026
SRJ Technologies has replaced both its chair and chief executive as it turns from international expansion toward operational delivery and revenue conversion. Ben Lumley will serve as interim CEO with an initial two-month review period, while Mark Lindh becomes chair.
Victor Sage
Victor Sage
4 Nov 2026
Lennox is replacing the head of its Building Climate Solutions segment with an internal executive while retaining the outgoing leader as a strategic adviser through February 2028. The transition preserves customer and leadership continuity, but the filing does not indicate any change to financial guidance.
Maxwell Dee
Maxwell Dee
3 Nov 2026
CSL has appointed ViiV Healthcare CEO Deborah Waterhouse to lead the biopharmaceutical group from 1 February 2027. Her arrival comes with a substantial UK-pound-denominated remuneration package and a mandate to renew the pipeline while simplifying operations.
Ada Torres
Ada Torres
21 Oct 2026
LGI Limited (ASX:LGI) will elevate current CEO Jarryd Doran to Managing Director and CEO while reshaping its board and executive team from 1 December. The restructure includes 5.861 million proposed options for Doran and other executives, with shareholder approval required for the grants.
Victor Sage
Victor Sage
14 Oct 2026

Browse the archive

Full archive